Skip to main content

We earn commissions from the providers listed here. No provider buys a position, a rating, or a listing. The order is set by hand, and we do not claim it is independent of what we earn. Advertising Disclosure

Manytreatments
Manytreatments
BrowseCategoriesCompareMedicationsBy State
TreatmentsWeight LossED TreatmentHair LossTRT
AboutFAQContact
CategoriesCompareMedicationsBy StateWeight LossED TreatmentHair LossTRTHow We Rate

manytreatments

Compare telehealth providers for weight loss, erectile dysfunction, hair loss, TRT, women's health, mental health, and premature ejaculation treatment. Find pricing, reviews, and licensed US doctors in all 50 states.

Trustpilot
Google Safe Browsing verified site

Treatments

  • Weight Loss
  • ED Treatment
  • TRT
  • Hair Loss
  • Women's Health
  • PE Treatment
  • Mental Health
  • View All Treatments →

Top Brands

  • Hims
  • Medvi
  • Ro
  • Shed
  • Eden
  • Sesame Care
  • Maximus
  • Peter MD
  • View All Brands →

Resources

  • Compare Brands
  • Browse by State
  • Medications
  • Tools
  • Guides
  • Cost Guides
  • Statistics & Price Indexes
  • FAQ
  • About Us
  • Contact Us
  • How We Rate
  • Sitemap

Legal

  • Privacy Policy
  • Terms of Service
  • Affiliate Disclosure
  • Medical Disclaimer
  • Editorial Policy
  • Cookie Policy
  • California Privacy Notice (CCPA)
  • Accessibility Statement

Follow Us

  • Medium
  • YouTube
  • LinkedIn
  • Twitter/X
  • Instagram
  • Threads
© 2026 ManyTreatments.com. All rights reserved.Advertising DisclosureWe may earn commissions from affiliate links.

Content is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved for safety, effectiveness, or quality. Medical Disclaimer

  1. Home
  2. States
  3. Indiana
  4. Weight Loss
Telehealth treatment comparison background
Eric GoldWritten by Eric GoldEditor-in-Chief
Updated onOctober 09, 2026

Online Weight Loss Treatment in Indiana All 14 Providers Compared for 2026

In Indiana, you can start a weight loss prescription online after a consultation by video or phone. Insurance coverage varies by plan.

Fast Approval
Free Shipping
Exclusive Coupons
Online Prescription
Compare weight loss treatment providers in Indiana

Key Takeaways

Best weight loss telehealth in Indiana: HealthRx and Strut for the lowest price at $99 per month for compounded semaglutide; Medvi for doctor-guided care with free dietician visits included, at $179 for your first month and $299 per month after that. Indiana offers full insurance parity, so your online weight loss consultation gets reimbursed at the same rate as an in-person visit - a financial advantage many states don't provide. Clinic Secret, Nurx, and UrWay Health are not among the fourteen platforms compared here, so check their own sites directly if you want to consider them. Fourteen weight loss telehealth providers total serve the state.

Who This Is For

This is for
  • Indiana residents who want a licensed Indiana provider.
  • You want access to 14 Indiana-available weight loss providers without driving to a clinic.
  • You're comfortable completing an online consultation, by video or phone, before starting treatment.
Not for
  • Not for anyone who wants a same-day in-person exam and prescription from a local clinic.
  • The FDA-approved labeling for Wegovy and Zepbound covers weight reduction in adults with a BMI of 30 or higher, and in adults with a BMI of 27 or higher who have at least one weight-related condition such as type 2 diabetes or high blood pressure. If you are near either number, ask a licensed provider where you fall before choosing a platform.
  • If you are pregnant or planning a pregnancy, the Wegovy label directs you to stop semaglutide once pregnancy is recognized and two months before a planned pregnancy, so raise it at intake.
  • If you are breastfeeding, ask the provider what the label for the specific medication says, because the labels differ.
  • If you have a history of disordered eating, tell the provider at intake, because it is part of what a prescriber weighs before starting a weight loss medication.
  • If you have had bariatric surgery or are considering it, tell the provider at intake, because it changes what a prescriber will consider.
  • A remote visit cannot include a physical exam or in-office testing. If that matters for your situation, raise it with a licensed provider before choosing a platform.
  • If this is an emergency, call 911 or go to the nearest emergency room. Telehealth is not for emergency care.

These notes are not a medical screening: a licensed provider decides after an intake review whether a treatment is appropriate for you.

User Preferences & Indiana Availability

TrimRx is the top choice for 25% of users comparing weight loss providers on ManyTreatments in 2026, followed by Ro (16%) and Hers (14%).

16 licensed telehealth providers offer weight loss programs to Indiana residents. Indiana requires a live video consultation with a licensed in-state provider before any prescription is issued.

Medical Disclaimer: Content is for informational purposes only - not medical advice. Consult a licensed healthcare provider before any treatment. Learn more

Best Value
1
Ro logo

Wegovy® From $149/mo Plus Membership From $74/mo - Free Insurance Check

  • Full GLP-1 suite: Zepbound®, Wegovy® pill and pen, semaglutide and more
  • Free insurance check shows what your plan covers before you pay
  • Tirzepatide (Zepbound®) averaged up to 20.9% body weight loss in the 72-week SURMOUNT-1 trial; individual results vary
  • On-demand provider coaching and support, 100% online
LegitScript lists Ro as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
9.3
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Most Popular
2
Medvi logo

First Month $179, Then $299/mo With No Membership Fee

  • Doctor-guided compounded GLP-1 care, 100% online. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free dietician visits and care coaching included with your plan
  • Doctor-formulated plans adjusted as your body responds
  • Fast, discreet shipping to your door
LegitScript lists Medvi as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
3
Strut logo

Start for Free - Free MD Visit, Follow-Up Care & Shipping

  • Compounded injectable semaglutide prescribed by U.S.-licensed physicians. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free online MD visit and free follow-up care included
  • Free shipping - fill through Strut's pharmacy network or your local pharmacy
  • Your Strut doctor manages your dosage increase plan as treatment progresses
Strut displays LegitScript certificate 11142478, checked September 19, 2026Cert. 11142478September 19, 2026
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
4
Fridays logo

Compounded Semaglutide From $150/mo on Prepaid Plans

  • Compounded semaglutide from $150/mo, tirzepatide from $240/mo on prepaid plans
  • Insurance concierge works to maximize your coverage
  • GLP-1 microdosing option and a custom plan in under 3 minutes
Fridays displays LegitScript certificate 18528873, checked September 19, 2026Cert. 18528873September 19, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
5
Sprout Health logo

Compounded Semaglutide From $199/mo - Free 2-Minute Quiz

  • Compounded semaglutide and tirzepatide from $199/mo. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Prescribed by US-licensed clinicians with personalized dosing - no waiting room
  • Ships from a US pharmacy in discreet, refrigerated packaging
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
6
Eden logo

Start for Just $129 First Month. Same Price Every Dose

  • Compounded semaglutide & tirzepatide custom dosed. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free consults with US doctors, 24/7 messaging
  • Fast discreet shipping, cancel anytime no contracts
  • Ongoing optimization for your health goals
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
7
HealthRx logo

Compounded GLP-1 From $99/mo - Full Refund If You Are Not Approved

  • Compounded semaglutide & tirzepatide GLP-1, from $99/mo on the 12-month plan ($133/mo for 3 months)
  • No insurance needed - full refund if a licensed provider doesn't approve you
  • Physician-supervised online intake, and HealthRx displays LegitScript certification seal 50087439, which we checked with LegitScript on September 19, 2026
  • Ships from US pharmacies in 24-48 hours with fast, free delivery
HealthRx displays LegitScript certificate 50087439, checked September 19, 2026Cert. 50087439September 19, 2026
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
View 7 More Weight Loss Providers
8
Peter MD logo

Starting at $209/mo - $100 Off Your First Month

  • Compounded semaglutide option available. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Board-certified obesity medicine specialists
  • All supplies & shipping included in price
  • No surprise bills - transparent pricing
9.5
ExceptionalScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
9
Skinny.Rx logo

25% Lower Prices on All GLP-1s - Semaglutide From $149.25/mo

  • Compounded injectable semaglutide from $149.25/mo, tirzepatide tablets from $224.25/mo. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • FDA-approved Wegovy® and other GLP-1s available, plus daily oral options via membership
  • Clinician-guided care, not just a prescription - ongoing dose adjustments and provider check-ins
  • App with care team support, medication reminders and weight trend tracking
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
10
Hers logo

FDA-Approved GLP-1s From $149/mo Plus Required $149/mo Membership

  • Oral GLP-1 options from $149/mo, semaglutide from $199/mo
  • Personal plan with ongoing care from day 1 via membership
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Our Top Choice
11
TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
TrimRx displays LegitScript certificate 31417191, checked September 19, 2026Cert. 31417191September 19, 2026
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
12
Hims logo

FDA-Approved GLP-1s From $149/mo Plus Required $149/mo Membership

  • Oral GLP-1 options from $149/mo, semaglutide from $199/mo
  • Personal plan with on-demand care from day 1 via membership
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
13
Shed logo

Semaglutide From $159/mo - 120-Day Refund If You Don't Lose 5%

  • Compounded semaglutide as low as $159/mo, tirzepatide from $239/mo. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • 120-day money-back guarantee - refund if you don't lose 5%, per Shed's terms
  • 100% online visit and checkout - prescription shipped straight to your door
  • Health coaching support included alongside your GLP-1 program
Shed displays LegitScript certificate 44256860, checked September 19, 2026Cert. 44256860September 19, 2026
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
14
Sesame Care logo

Wegovy Pill From $149/mo Plus Care Plans From $59/mo - Same-Day Visits

  • Cash-pay GLP-1 medications as low as $149/mo, insurance accepted for weight loss meds
  • Ongoing video visits, dedicated provider, labs and messaging from $59/mo
  • 1M+ patients treated with 95% patient satisfaction
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Our Top Choice
TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
9.4
★★★★★
Visit TrimRx

About This Comparison

Our Editorial Standards

This weight loss provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, and service areas. Our ratings are editorial judgments, not tallies of reviews.

Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers

Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.

Independent ResearchNo paid placements
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated October 9, 2026
Licensed Providers OnlyAll listed services are US-licensed

Online Weight Loss Treatment in Indiana: All 14 Providers Compared for 2026

Eric GoldWritten by Eric GoldEditor-in-Chief
18 min readUpdated October 9, 2026

Table of Contents

14 telehealth weight loss providers operate in Indiana in 2026. Compare pricing, medications, and insurance options including Wegovy, semaglutide, and tirzepatide.

Which Weight Loss Providers Actually Work in Indiana

Fourteen telehealth weight loss platforms are active in Indiana right now: TrimRx, Medvi, Ro, Strut, Shed, Fridays, Eden, HealthRx, Sprout Health, Peter MD, Skinny.Rx, Hers, Hims, and Sesame Care. Clinic Secret, Nurx, and UrWay Health, three services that get frequent search traffic, are not among these fourteen, so check their own sites directly if you want to consider them.
This is a stronger lineup than many Midwestern states see. You have genuine choices across every budget and treatment style: self-pay compounding programs starting under $200 a month, platforms built to fight insurance denials for brand-name Wegovy, and marketplace options where you pay per visit with no subscription commitment. The sections below break down what each approach actually costs in Indiana and who each one makes sense for.
One thing that separates Indiana from states like Texas or Florida is that Indiana has full telehealth insurance parity. Your insurance company is legally required to reimburse an online weight loss consultation at the same rate it would pay for an in-person visit. That changes the math on several providers here, especially Ro, which lets you check what your plan covers before you pay anything.

Indiana's Insurance Parity Law and What It Means for Your Weight Loss Costs

Indiana is one of the states with full telehealth insurance parity, and that is not a small thing when you are looking at weight loss treatment. It means your insurer cannot pay less for a telehealth visit with an online weight loss doctor than it would for the same visit in a cardiologist's waiting room. In practice, if your plan covers obesity medicine consultations at all, you are not penalized for doing them online.
Indiana Medicaid also covers telehealth weight loss consultations, which matters if you are on Hoosier Healthwise, Healthy Indiana Plan, or another Medicaid managed care plan. The caveat most relevant to weight loss: Medicaid coverage of GLP-1 medications like Ozempic or Wegovy in Indiana is limited and requires prior authorization with documented comorbidities.
If you have commercial insurance through an Indiana employer, your best starting point is Ro. Ro runs a free insurance check that shows what your plan covers before you pay, which is worth doing first if your employer plan technically covers a GLP-1 but buries the approval in paperwork. Sesame Care also accepts insurance for weight loss visits on a pay-per-visit basis if you want a lower-commitment starting point.

The Most Affordable Weight Loss Programs for Indiana Residents Paying Out of Pocket

If you are uninsured or your insurance will not cover GLP-1 medications, HealthRx and Strut are your cheapest starting points in Indiana, both from $99 per month for compounded semaglutide. Eden follows at $129, Skinny.Rx at $149.25, and Fridays at $150 on its prepaid plan. Ro sits higher than its headline suggests, because its $149 medication price is billed on top of a membership from $74 a month, $223 all-in. Medvi is priced above all of them at $299 per month on refills, after a $179 first month, all-inclusive for the medication, the prescriber consultation, and ongoing follow-up, plus free dietician visits and care coaching that the cheaper options do not include. With a rating of 9.2 out of 10, Medvi carries the Most Popular badge for weight loss in Indiana, but it is the most expensive ongoing program on this page.
Skinny.Rx is another budget-focused option with straightforward monthly pricing for compounded semaglutide. The pricing model is similarly transparent. If Medvi is sold out or has a waitlist in your area, Skinny.Rx is a reasonable fallback. Shed is worth knowing about too, sitting at 9.0 out of 10, offering compounded GLP-1 medications with behavioral coaching built in. If you want a little more structure than a pure prescription-and-ship model, Shed adds that layer without jumping to premium pricing.
Sesame Care takes a different approach entirely. It is a pay-per-visit marketplace, meaning you pay for individual consultations rather than a monthly subscription. If you need a one-time evaluation to get a prescription started, or if you already have a pharmacy source and just need a licensed Indiana prescriber to write the order, Sesame Care is often the most cost-efficient route. There is no ongoing membership fee, which helps if you are not sure you want to commit to a program yet.

Getting Semaglutide and Tirzepatide in Indiana: Brand Names vs. Compounded

Indiana residents can access both brand-name and compounded versions of GLP-1 medications through telehealth. The brand-name options are Wegovy and Ozempic for semaglutide, and Zepbound for tirzepatide. Compounded versions of both semaglutide and tirzepatide are available through licensed 503B pharmacies, which are the federally-regulated facilities that compound medications at scale. Indiana telehealth providers sourcing from 503B pharmacies are operating within that framework. Since the FDA declared the semaglutide and tirzepatide shortages resolved in December 2024 and February 2025, compounding now turns on a documented clinical need rather than a shortage listing, so ask any platform what its compounding is based on.
The reason compounded GLP-1s exist at all is a supply chain issue that has stretched for years. When the FDA lists a drug as in shortage, licensed compounders are permitted to produce that medication. Both semaglutide and tirzepatide have been on shortage lists, which is what made platforms like Medvi, Sprout Health, and Shed viable. Both listings have since ended, semaglutide on February 21, 2025 and tirzepatide two months before that, and the wind-down an ended shortage requires of compounders has already run. This is worth keeping in mind when you are choosing a provider: a platform like Ro that can also handle brand-name prescriptions gives you a fallback if compounded availability shifts.
Compounded semaglutide in Indiana runs roughly $99 to $199 per month depending on the platform. Brand-name Wegovy without insurance can run $1,300 to $1,500 per month at retail, which is why checking what your plan covers before you pay is worth the five minutes if your employer plan covers weight loss medications. Compounded tirzepatide tends to be priced slightly higher than semaglutide through most platforms. If you are specifically searching affordable tirzepatide in Indiana, Sprout Health is among the platforms offering it with all-inclusive monthly pricing.

Can You Get Phentermine Online in Indiana?

Phentermine is a controlled substance, which means its prescribing rules are different from semaglutide or metformin. Under current DEA regulations, controlled substances can be prescribed via telehealth without an in-person visit, but only if the provider is using a platform that meets specific requirements for identity verification and prescriber registration. Not every telehealth platform prescribes phentermine, partly because of the administrative burden and partly because many weight loss platforms have shifted focus entirely to GLP-1s.
Indiana does not have additional state-level restrictions on phentermine beyond the federal DEA rules, which is helpful. This means that if you find a licensed Indiana telehealth prescriber on a compliant platform, you can get phentermine prescribed online in Indiana. Peter MD is among the platforms operating in Indiana that have broader prescription authority, including controlled substances, compared to platforms that only handle GLP-1 medications. Sesame Care's marketplace model also gives you access to licensed Indiana physicians who can evaluate you for phentermine.
Keep in mind that phentermine is typically prescribed short-term, usually 12 weeks or less, and is most commonly used as a bridge or if you are not a candidate for GLP-1s. The standard BMI threshold applies in Indiana: 30 or above without a comorbidity, or 27 and above with a documented condition like hypertension, type 2 diabetes, or sleep apnea. If you are right at that threshold, leading with your comorbidity in your intake form matters for getting approved.

Comparing the Big-Name Weight Loss Platforms Available in Indiana

Peter MD carries the highest rating among Indiana-available providers at 9.5 out of 10, with Hims and Strut just behind at 9.4 out of 10. Hims is the stronger choice for weight loss specifically because it has a dedicated weight loss program with compounded semaglutide, a clean mobile app experience, and transparent pricing. Strut's 9.4 rating comes largely from its hair loss and men's health compounding products, which are excellent, but it is not primarily a weight loss platform.
Ro is rated 9.3 out of 10, and Medvi is rated 9.2 out of 10. Ro's strength is its breadth: it carries the full GLP-1 suite including Zepbound and both Wegovy forms, has licensed Indiana clinicians on staff, and covers other conditions like ED and hair loss under one account if you want that convenience. Medvi's strength is its care model: doctor-guided compounded semaglutide with free dietician visits and ongoing care coaching bundled into its monthly price, which is $299 on refills after a $179 first month.
Hers, rated 9.1 out of 10, is worth highlighting separately for Indiana women searching for weight loss treatment. It is a women's health platform that includes weight loss alongside birth control, hair loss, and mental health services. If you want a single telehealth relationship that covers multiple health concerns rather than having separate accounts for each, Hers makes that practical.

Why Weight Loss Telehealth Access Looks Different in Indiana Than in Coastal States

Indiana has a documented obesity rate that consistently ranks among the higher ones nationally, and the state's healthcare infrastructure, particularly in rural areas like the northern lake counties, southern agricultural regions, and smaller cities between Indianapolis and Fort Wayne, is stretched thin for in-person obesity medicine specialists. There are relatively few board-certified obesity medicine physicians practicing in Indiana outside of major health systems like IU Health or Ascension. Telehealth weight loss programs are not a luxury add-on here for many Indiana residents: they are the most practical way to access a prescriber with weight loss expertise at all.
That context makes Indiana's full insurance parity law more consequential than it might be in a state like New York or California where there are more in-person options. The parity law means that Indiana insurers cannot push you toward an in-person visit as a condition of coverage for telehealth weight loss consultations. If your plan covers weight loss treatment, online counts equally.
Indiana residents in Indianapolis, Fort Wayne, Evansville, South Bend, and Carmel have the same access to all 14 providers listed here as anyone in a major metro. The telehealth model removes geography from the equation entirely. What it does not remove is the insurance pre-authorization process for GLP-1s, which is the same challenge Indiana residents face whether they use an online provider or walk into an IU Health clinic. The advantage of a platform like Ro is that you can see what your plan covers before you pay, which tells you quickly whether the insurance route is worth chasing at all.

Matching the Right Indiana Weight Loss Provider to Your Situation

If your priority is the lowest monthly cost, start with HealthRx or Strut at $99 per month, then Eden at $129, Skinny.Rx at $149.25, and Fridays at $150. Ro is not in that tier: its $149 medication price rides on top of a membership from $74 a month, $223 all-in. If you want compounded semaglutide with free dietician visits and care coaching bundled in and are willing to pay the most on this page for it, Medvi is $299 per month on refills after a $179 first month. That care model is what the money buys, and it is still priced well below what you would pay at a direct-to-consumer pharmacy filling a brand-name prescription.
If you have Indiana commercial insurance and want to try to get brand-name Wegovy or Ozempic covered, go to Ro first. Ro's insurance check shows what your plan covers before you pay anything.
If you are new to weight loss medications and want hand-holding through the process, including nutritional coaching and check-ins, Sprout Health is a starting point worth considering. If you want a broad platform with a strong mobile experience and do not need help with insurance, Hims for men or Hers for women are the options to look at. If you want no subscription commitment and just need a consultation to get started, Sesame Care's pay-per-visit model in Indiana removes all the recurring cost risk while you figure out whether this treatment approach works for you.

Beyond Semaglutide: Other Weight Loss Medications Available Through Indiana Telehealth

Indiana telehealth prescribers can write for the full range of FDA-approved weight loss medications, not just GLP-1s. Liraglutide (the daily injectable sold as Saxenda for weight loss) is available and is sometimes chosen when semaglutide is back-ordered or when a prescriber wants to start someone at a lower potency. Metformin is frequently prescribed off-label for weight management, particularly if you are pre-diabetic, and it is inexpensive enough that even without insurance it is rarely a budget concern.
Bupropion-naltrexone, sold as Contrave, is another option available through Indiana telehealth platforms. It works differently from GLP-1s, targeting brain pathways related to appetite and reward rather than gut hormones. Some providers prefer it if you have cardiovascular contraindications to GLP-1s or you would rather take a daily oral pill than inject. Peter MD is among the Indiana-available platforms most likely to offer this range of options, given its broader scope beyond GLP-1 specialty.
Tirzepatide through Zepbound (brand) or compounded tirzepatide is the other major GLP-1 option beyond semaglutide. Clinical trial data showed tirzepatide producing larger average weight loss than semaglutide in head-to-head comparisons, which is why there is so much search interest for affordable tirzepatide in Indiana specifically. Compounded tirzepatide is available through several Indiana-active platforms including Sprout Health. Pricing is typically slightly higher than compounded semaglutide, but it is still a fraction of Zepbound's retail price without insurance.

Frequently Asked Questions

How many telehealth weight loss providers are available in Indiana?

Fourteen telehealth weight loss platforms are currently available to Indiana residents: TrimRx, Medvi, Ro, Strut, Shed, Fridays, Eden, HealthRx, Sprout Health, Peter MD, Skinny.Rx, Hers, Hims, and Sesame Care. Three platforms that come up in online searches are not among these fourteen: Clinic Secret, Nurx, and UrWay Health. If you have been reading comparison articles that include those three, check their own sites directly to confirm what they offer in Indiana. The 14 that do operate here cover the full range from budget compounding programs under $200 per month to insurance-navigating platforms for brand-name Wegovy.

Is Ro available in Indiana and does it help with insurance for Wegovy?

Yes, Ro is fully available in Indiana and it is one of the stronger choices if you have commercial insurance that may cover Wegovy. Ro's free insurance check shows what your plan covers before you pay, which matters because insurance approvals for GLP-1 weight loss medications typically require documentation of BMI, comorbidities, and prior treatment attempts. Indiana's insurance parity law means your insurer must treat a Ro telehealth consultation the same as an in-person visit financially. Ro is rated 9.3 out of 10 and is one of the most visible platforms for Indiana residents searching for Wegovy access.

What is the cheapest weight loss medication program available in Indiana?

HealthRx and Strut offer the lowest pricing for compounded semaglutide in Indiana, both from $99 per month. Eden follows at $129, Skinny.Rx at $149.25, and Fridays at $150, while Ro reaches $223 once its $74 membership is added to its $149 medication price. Medvi runs $299 per month on refills, after a $179 first month, with no separate pharmacy fees or consultation add-ons, and that price includes the medication, prescriber evaluation, ongoing follow-up, plus free dietician visits and care coaching that the cheaper options do not include. Medvi is rated 9.2 out of 10 and remains the platform most recommended for Indiana residents who want that level of support. If you want to avoid a subscription entirely, Sesame Care's pay-per-visit model can reduce your upfront commitment while you evaluate whether GLP-1 treatment is right for you.

Can I get phentermine prescribed online in Indiana?

Yes, phentermine can be prescribed via telehealth in Indiana. Phentermine is a Schedule IV controlled substance, so the prescribing platform must comply with DEA telehealth rules around identity verification and prescriber registration. Indiana does not add state-level restrictions beyond the federal requirements. Platforms operating in Indiana that have broader prescription authority, including controlled substances, include Peter MD. The standard eligibility threshold applies: BMI of 30 or higher, or 27 and above with a documented comorbidity like hypertension or type 2 diabetes. Phentermine is typically prescribed for short durations, usually no more than 12 weeks, and some providers use it alongside GLP-1 therapy.

Does Indiana Medicaid cover weight loss medications prescribed through telehealth?

Indiana Medicaid covers telehealth consultations for weight loss due to the state's full insurance parity rules, so the visit itself is covered under Hoosier Healthwise and Healthy Indiana Plan managed care options. Medication coverage is more complicated. GLP-1 medications like Ozempic may be covered for diabetes management under Indiana Medicaid with prior authorization, but coverage for weight loss as the primary indication is more restricted and varies by managed care plan. Compounded semaglutide and tirzepatide are generally not covered by Medicaid at all. If you are on Indiana Medicaid and need weight loss medication, a consultation with any of the 14 Indiana-available platforms will clarify exactly what your specific plan will approve.

What is the clinical BMI threshold to qualify for weight loss medication in Indiana?

The standard clinical threshold applied by Indiana telehealth providers mirrors national guidelines: a BMI of 30 or above qualifies without any other conditions required. This threshold applies regardless of which platform you use.

Is compounded semaglutide legal and safe to use in Indiana?

Compounded semaglutide is legal in Indiana when it is produced by a licensed 503B outsourcing facility and prescribed through a licensed Indiana telehealth provider. 503B pharmacies are federally regulated by the FDA and must meet pharmaceutical-grade manufacturing standards. The legal basis for mass compounding of GLP-1s rested on FDA shortage designations for semaglutide and tirzepatide, which the FDA declared resolved in December 2024 and February 2025; compounding now depends on patient-specific clinical need. Indiana residents using platforms like Medvi, Sprout Health, Shed, or Skinny.Rx are getting compounded semaglutide through this framework. You should ask any provider you are evaluating whether they source from a 503B facility specifically, since that distinction matters for safety and legal compliance.

How does Indiana's telehealth insurance parity law affect the cost of weight loss treatment?

Indiana's full telehealth insurance parity law means your insurer must reimburse an online weight loss consultation at the same rate it would pay for an identical in-person visit. You cannot be charged a higher copay or coinsurance because the visit happened over video or phone. For Indiana residents with commercial insurance from an employer plan, this makes telehealth weight loss consultations through Ro financially equivalent to visiting a local obesity medicine specialist, if your plan covers that service at all. It also means insurers cannot deny coverage for telehealth specifically. This parity protection does not extend to the medications themselves, where prior authorization requirements still apply regardless of how you received the prescription.

Which Indiana weight loss telehealth platform is best for women?

Hers is the strongest option for Indiana women who want a platform designed specifically around women's health. It covers weight loss alongside birth control, hair loss, mental health support, and general wellness under one account, rated 9.1 out of 10. If weight loss is your only concern and cost is the priority, HealthRx or Strut at $99 per month work regardless of gender; Medvi is the most expensive option here at $299 per month on refills, after a $179 first month, and what the extra buys is free dietician visits and care coaching. Sprout Health is a strong option for Indiana women who are new to GLP-1 medications and want structured coaching and lifestyle support alongside the prescription, rather than a medication-only approach.

What is the difference between Wegovy and compounded semaglutide available in Indiana?

Wegovy is the FDA-approved brand-name version of semaglutide specifically indicated for weight management, manufactured by Novo Nordisk. It goes through FDA approval, and every batch meets consistent potency and formulation standards. Compounded semaglutide contains semaglutide, the active ingredient in Wegovy, but it is not FDA-approved as a finished drug product and is not reviewed by the FDA for safety, effectiveness, or quality. The practical differences for most Indiana residents come down to cost and insurance. Wegovy without insurance runs $1,300 to $1,500 per month at retail. Compounded semaglutide through Indiana platforms ranges from $99 per month through HealthRx or Strut up to $299 per month through Medvi, which charges $179 for your first month and bundles free dietician visits and care coaching into that price. Insurance will only cover brand-name Wegovy, not compounded versions, which is why Ro's free insurance check is the fastest way to find out whether brand-name Wegovy is within reach on your plan.

Sources & References

Our comparisons are informed by official sources and regulatory guidelines. We encourage you to verify information with authoritative sources.

  • CCHP Telehealth Policy - IndianaIndiana state telehealth laws, online prescribing rules, and insurance reimbursement policies maintained by the Center for Connected Health Policy.
  • CDC - Adult Obesity FactsCDC data: over 40% of U.S. adults have obesity, with $173 billion in annual medical costs. National prevalence and demographic breakdowns.
  • NIDDK - Weight ManagementNIDDK evidence-based guidance on weight management: BMI thresholds, GLP-1 medications, and health risks of obesity.
  • America's Health Rankings - Cardiovascular Health in IndianaIndiana cardiovascular disease prevalence, including heart attack, stroke, and coronary heart disease.
  • America's Health Rankings - Diabetes in IndianaIndiana diabetes prevalence among adults, sourced from CDC BRFSS data.
  • NIMH - Mental Illness StatisticsNIMH data: 1 in 5 U.S. adults experience mental illness annually. National prevalence by condition, age, and demographic.
  • America's Health Rankings - Obesity in IndianaIndiana adult obesity prevalence data from the CDC Behavioral Risk Factor Surveillance System.

Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards

TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
9.4
★★★★★
Visit TrimRx

Compare Top Weight Loss Providers

See how the top weight loss providers in Indiana stack up against each other:

Ro vs MedviRo vs StrutRo vs FridaysView All Comparisons →

More Telehealth Options in Indiana

Explore other telehealth treatments available in Indiana:

Erectile Dysfunction in IndianaHair Loss in IndianaWomens Health in IndianaPremature Ejaculation in IndianaMental Health in IndianaWeight Loss NationwideGLP-1 Price Index 2026How to Get Ozempic Without Insurance (2026 Guide)All Indiana TreatmentsBrowse All States →
Eric Gold
Eric GoldEditor-in-Chief

Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.

Medical Disclaimer: The information provided on this page is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. Telehealth regulations in Indiana may change. Always verify requirements with your chosen provider. Read our full medical disclaimer.

Regulatory noticeRegulatory note (verified October 8, 2026): On February 20, 2026 the FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455) citing misbranding under sections 502(a) and 502(bb) of the FD&C Act. Reviewing medvi.io in December 2025, the FDA said labels bearing "MEDVi" implied MEDVi compounds the drugs when it does not, and that site copy presenting the compounded drug as having the same active ingredient as Wegovy and Ozempic, and as Mounjaro and Zepbound, implied an FDA approval compounded drugs do not have. The letter adds that introducing or delivering the products it identifies into interstate commerce is a prohibited act under section 301(a), that receiving them in interstate commerce and delivering or offering to deliver them also violates section 301(c), and that a compounded drug product must meet the conditions of section 503A or 503B of the FD&C Act to be exempt from certain requirements, including the new drug approval requirements. When we checked FDA's warning letter index for MEDVi, LLC on October 8, 2026 it showed no response letter and no close-out letter entered against it, so the letter is not closed out on the public record. MEDVi states medvi.io is affiliate-operated rather than company-operated; we could not verify that, and the letter is addressed to MEDVi, LLC. Read the FDA letter

Regulatory noticeRegulatory note (verified October 8, 2026): The FDA reviewed struthealth.com in December 2025 and, on February 20, 2026, issued Strut Health, LLC a warning letter, MARCS-CMS 721448. It raises two separate problems. Pictured product labels carry the "Strut" name, which the agency said represents Strut as the compounder of the semaglutide and tirzepatide products when it is not. The letter also quotes three claims from the site, among them "Generic Zepbound, Mounjaro", along with site copy naming semaglutide and tirzepatide as the active ingredient in the brand medications. Because compounded drugs hold no FDA approval, the FDA said wording of that kind implies one, and it cited misbranding under sections 502(a) and 502(bb) of the FD&C Act. The letter adds that introducing or delivering the products it identifies into interstate commerce is a prohibited act under section 301(a), that receiving them in interstate commerce and delivering or offering to deliver them also violates section 301(c), and that a compounded drug product must meet the conditions of section 503A or 503B of the FD&C Act to be exempt from certain requirements, including the new drug approval requirements. When we checked FDA's warning letter index for Strut Health, LLC on October 8, 2026 it showed no response letter and no close-out letter, so we treat the matter as open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): One sentence is all that FDA warning letter MARCS-CMS 715879 quotes. Sent to Sprout Health Partners LLC on September 9, 2025 after an August 2025 review of joinsprouthealth.com, it cites the line "GLP-1 medications are FDA-approved and backed by extensive clinical research..." Appearing on pages offering compounded semaglutide and tirzepatide, that statement implied to the agency that the compounded products themselves are FDA-approved, which they are not, and it was cited as misbranding under FD&C Act 502(a) and 502(bb). A search of FDA’s warning letter index turns up no close-out letter, so the matter appears open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): Eden Health International Inc. was sent FDA warning letter MARCS-CMS 728279 on June 8, 2026, following an agency review of tryeden.com in March 2026. The letter lists two findings. The first is the "Eden" name on pictured labels for compounded semaglutide and tirzepatide, which the FDA said represents Eden as the compounder when it is not. The second is the site’s description of its sourcing as "FDA-licensed 503(a) outsourcing facilities," a designation the agency says does not exist, because the FD&C Act creates no FDA approval or license for pharmacies or outsourcing facilities. Both were cited as misbranding under sections 502(a) and 502(bb). FDA has posted no close-out letter, so the matter reads as open. Read the FDA letter

Verification limitationVerification note (checked August 23, 2026): we could not identify the legal entity behind HealthRx through public records. Its website does not name an operating company, its domain registration is privacy-shielded, and we could not confirm a listing in any business registry or accreditation database we checked. This is not a finding of wrongdoing. It means our usual checks, including our search of FDA enforcement records, could only be run against the brand name and domain rather than a confirmed company.

Regulatory noticeRegulatory note (verified August 22, 2026): Skinny.Rx operates as SkinnyRx, but the legal entity is Lean Rx, Inc., and that is the name on FDA warning letter MARCS-CMS 717989, dated February 20, 2026. Following a December 2025 review of skinnyrx.com, the agency objected to the "SkinnyRx" name on pictured labels, saying it implies SkinnyRx compounds the drugs itself, and to three marketing lines, including "Get access to the same active ingredient as name-brand GLP-1 medications" and "It contains the same active ingredient as FDA-approved medications." Compounded semaglutide and tirzepatide are not FDA-approved, so the FDA read those lines as implying an approval that does not exist and classed the products as misbranded. FDA's warning letter index carries no close-out letter for MARCS-CMS 717989, so read the matter as unresolved. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): Hers is a brand of Hims & Hers Health, Inc., and the FDA wrote to that company twice on September 9, 2025, once for each brand. The Hers letter, MARCS-CMS 716825, went to chief executive Andrew Dudum after an August 2025 review of forhers.com. It quotes two claims made for compounded semaglutide: "Weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." The agency’s position is that compounded products carry no FDA approval, so claims like these imply a sameness with approved medicines that has not been established, making the products misbranded. FDA’s index lists neither a response nor a close-out letter, so the matter stands open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): On September 9, 2025 the FDA sent Hims & Hers Health, Inc. a warning letter covering the Hims brand, MARCS-CMS 716567, drawn from a review of hims.com the previous month. Two lines about compounded semaglutide are quoted in it: "Same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." Compounded drug products are not FDA-approved, and the agency said phrasing of this sort suggests otherwise, which is what makes the products misbranded under FD&C Act sections 502(a) and 502(bb). A companion letter went to the same company that day for its Hers brand. No close-out letter appears in FDA’s index; treat this as open. Read the FDA letter